Cargando…

Comparative Effectiveness of Complete Revascularization Strategies in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A Bayesian Network Meta-Analysis

Whether fractional flow reserve (FFR) should be available for revascularization in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease (MVD) is controversial. We aimed to compare the efficacy of various complete revascularization (CR) regimens for STEMI patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Lingyue, Guo, Wenqin, Huang, Weichao, Wang, Lili, Mo, Fanrui, Chen, Xiehui, Li, Chaoyang, Huang, Siquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496298/
https://www.ncbi.nlm.nih.gov/pubmed/34631826
http://dx.doi.org/10.3389/fcvm.2021.724274
_version_ 1784579727622668288
author Zhao, Lingyue
Guo, Wenqin
Huang, Weichao
Wang, Lili
Mo, Fanrui
Chen, Xiehui
Li, Chaoyang
Huang, Siquan
author_facet Zhao, Lingyue
Guo, Wenqin
Huang, Weichao
Wang, Lili
Mo, Fanrui
Chen, Xiehui
Li, Chaoyang
Huang, Siquan
author_sort Zhao, Lingyue
collection PubMed
description Whether fractional flow reserve (FFR) should be available for revascularization in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease (MVD) is controversial. We aimed to compare the efficacy of various complete revascularization (CR) regimens for STEMI patients with MVD. The PubMed and Cochrane Library databases and clinicaltrial.gov were searched for the randomized controlled trials (RCTs) comparing the FFR-guided CR, angiography-guided CR, and culprit-only revascularization (COR) strategies in STEMI patients with MVD. A Bayesian random-effect model was employed to synthesize the evidence in network meta-analysis. We used relative risk (RR) and 95% credible interval (CrI) as measures of effect size. The primary endpoint was the composite outcome of all-cause mortality or myocardial infarction (MI). Twelve RCTs were included. Angiography-guided CR showed a lower event rate of the composite outcome (RR, 0.68; 95%CrI, 0.50–0.87), all-cause mortality (RR, 0.75; 95%CrI, 0.55–0.96), MI (RR, 0.63; 95%CrI, 0.43–0.86), and repeat revascularization (RR, 0.36; 95% CrI, 0.24–0.55) compared with COR. Additionally, angiography-guided CR had a lower risk of primary outcome (RR, 0.64; 95%CrI, 0.38–0.94) and MI (RR, 0.58; 95%CrI, 0.31–0.92) than FFR-guided CR. The difference between the FFR-guided CR and COR in terms of composite outcome, all-cause mortality, and MI was similar. Angiography-guided CR was associated with the highest probability of optimal treatment for the primary outcome (98.5%), followed by FFR-guided CR (1.2%) and COR (0.3%). STEMI patients with MVD benefitted more from angiography-guided CR than from FFR-guided CR. However, only one study compared the effectiveness of FFR-guided and angiography-guided PCI; thus, the comparison between FFR-guided and angiography-guided PCI relied on indirect evidence. Therefore, further studies directly comparing the effectiveness of these two CR strategies are warranted.
format Online
Article
Text
id pubmed-8496298
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-84962982021-10-08 Comparative Effectiveness of Complete Revascularization Strategies in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A Bayesian Network Meta-Analysis Zhao, Lingyue Guo, Wenqin Huang, Weichao Wang, Lili Mo, Fanrui Chen, Xiehui Li, Chaoyang Huang, Siquan Front Cardiovasc Med Cardiovascular Medicine Whether fractional flow reserve (FFR) should be available for revascularization in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease (MVD) is controversial. We aimed to compare the efficacy of various complete revascularization (CR) regimens for STEMI patients with MVD. The PubMed and Cochrane Library databases and clinicaltrial.gov were searched for the randomized controlled trials (RCTs) comparing the FFR-guided CR, angiography-guided CR, and culprit-only revascularization (COR) strategies in STEMI patients with MVD. A Bayesian random-effect model was employed to synthesize the evidence in network meta-analysis. We used relative risk (RR) and 95% credible interval (CrI) as measures of effect size. The primary endpoint was the composite outcome of all-cause mortality or myocardial infarction (MI). Twelve RCTs were included. Angiography-guided CR showed a lower event rate of the composite outcome (RR, 0.68; 95%CrI, 0.50–0.87), all-cause mortality (RR, 0.75; 95%CrI, 0.55–0.96), MI (RR, 0.63; 95%CrI, 0.43–0.86), and repeat revascularization (RR, 0.36; 95% CrI, 0.24–0.55) compared with COR. Additionally, angiography-guided CR had a lower risk of primary outcome (RR, 0.64; 95%CrI, 0.38–0.94) and MI (RR, 0.58; 95%CrI, 0.31–0.92) than FFR-guided CR. The difference between the FFR-guided CR and COR in terms of composite outcome, all-cause mortality, and MI was similar. Angiography-guided CR was associated with the highest probability of optimal treatment for the primary outcome (98.5%), followed by FFR-guided CR (1.2%) and COR (0.3%). STEMI patients with MVD benefitted more from angiography-guided CR than from FFR-guided CR. However, only one study compared the effectiveness of FFR-guided and angiography-guided PCI; thus, the comparison between FFR-guided and angiography-guided PCI relied on indirect evidence. Therefore, further studies directly comparing the effectiveness of these two CR strategies are warranted. Frontiers Media S.A. 2021-09-23 /pmc/articles/PMC8496298/ /pubmed/34631826 http://dx.doi.org/10.3389/fcvm.2021.724274 Text en Copyright © 2021 Zhao, Guo, Huang, Wang, Mo, Chen, Li and Huang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Zhao, Lingyue
Guo, Wenqin
Huang, Weichao
Wang, Lili
Mo, Fanrui
Chen, Xiehui
Li, Chaoyang
Huang, Siquan
Comparative Effectiveness of Complete Revascularization Strategies in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A Bayesian Network Meta-Analysis
title Comparative Effectiveness of Complete Revascularization Strategies in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A Bayesian Network Meta-Analysis
title_full Comparative Effectiveness of Complete Revascularization Strategies in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A Bayesian Network Meta-Analysis
title_fullStr Comparative Effectiveness of Complete Revascularization Strategies in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A Bayesian Network Meta-Analysis
title_full_unstemmed Comparative Effectiveness of Complete Revascularization Strategies in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A Bayesian Network Meta-Analysis
title_short Comparative Effectiveness of Complete Revascularization Strategies in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A Bayesian Network Meta-Analysis
title_sort comparative effectiveness of complete revascularization strategies in patients with st-segment elevation myocardial infarction and multivessel disease: a bayesian network meta-analysis
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496298/
https://www.ncbi.nlm.nih.gov/pubmed/34631826
http://dx.doi.org/10.3389/fcvm.2021.724274
work_keys_str_mv AT zhaolingyue comparativeeffectivenessofcompleterevascularizationstrategiesinpatientswithstsegmentelevationmyocardialinfarctionandmultivesseldiseaseabayesiannetworkmetaanalysis
AT guowenqin comparativeeffectivenessofcompleterevascularizationstrategiesinpatientswithstsegmentelevationmyocardialinfarctionandmultivesseldiseaseabayesiannetworkmetaanalysis
AT huangweichao comparativeeffectivenessofcompleterevascularizationstrategiesinpatientswithstsegmentelevationmyocardialinfarctionandmultivesseldiseaseabayesiannetworkmetaanalysis
AT wanglili comparativeeffectivenessofcompleterevascularizationstrategiesinpatientswithstsegmentelevationmyocardialinfarctionandmultivesseldiseaseabayesiannetworkmetaanalysis
AT mofanrui comparativeeffectivenessofcompleterevascularizationstrategiesinpatientswithstsegmentelevationmyocardialinfarctionandmultivesseldiseaseabayesiannetworkmetaanalysis
AT chenxiehui comparativeeffectivenessofcompleterevascularizationstrategiesinpatientswithstsegmentelevationmyocardialinfarctionandmultivesseldiseaseabayesiannetworkmetaanalysis
AT lichaoyang comparativeeffectivenessofcompleterevascularizationstrategiesinpatientswithstsegmentelevationmyocardialinfarctionandmultivesseldiseaseabayesiannetworkmetaanalysis
AT huangsiquan comparativeeffectivenessofcompleterevascularizationstrategiesinpatientswithstsegmentelevationmyocardialinfarctionandmultivesseldiseaseabayesiannetworkmetaanalysis